Multidisciplinary Association For Psychedelic Studies

Rating: 4.9 stars   699 reviews


1215 Mission Street Santa Cruz CA 95060 USA


Founded in 1986, the Multidisciplinary Association for Psychedelic Studies (MAPS) is a 501(c)(3) non-profit research and educational organization that develops medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics and marijuana. MAPS furthers its mission by: -Developing psychedelics and marijuana into prescription medicines -Training therapists and working to establish a network of treatment centers -Supporting scientific research into spirituality, creativity, and neuroscience -Educating the public honestly about the risks and benefits of psychedelics and marijuana MAPS envisions a world where psychedelics and marijuana are safely and legally available for beneficial uses, and where research is governed by rigorous scientific evaluation of their risks and benefits.


MAPS has completed two Phase 2 FDA studies using MDMA-assisted psychotherapy to treat PTSD, and is in the process of four other similar studies. MAPS also has a study looking at LSD-assisted psychotherapy for treating end-of-life anxiety, an outcome study of the benefits of ibogaine for opiate dependence, and a protocol to investigate medical marijuana to relieve symptoms of PTSD.

Target demographics:

Any person whose life may be aided by the transformative nature of psychedelic psychotherapy

Geographic areas served:


2015 Top-Rated Nonprofit
Write a Review
Invite Reviews Share This Nonprofit

See How 3Hrs Can Help

More Info


Promote This Nonprofit

GreatNonprofits badges allow you to raise awareness of your favorite nonprofits on your own web sites!

Review this charity on

Reviews for Multidisciplinary Association For Psychedelic Studies

Rating: 5 stars  

10 people found this review helpful

The Multi-disciplinary Association for Psychedelic Studies is providing a valuable role in researching novel medicines to treat and heal PTSD and other serious medical issues that currently do not have effective treatment modalities. By working closely with the Federal Drug Administration MAPS has successfully conducted an important Phase 2 Study for the treatment of PTSD with MDMA. I have been affiliated with MAPS since its inception, and have watched as this organization over the years has effectively taken a humanitarian role in the approval of medicines that may assist to relieve the disease and suffering of many people who are currently without hope. I highly recommend that anyone interested in the field of research and making a donation review the website at

I've personally experienced the results of this organization in...

The gratitude of the individuals who have participated in the FDA approved MDMA PTSD study.

When was your last experience with this nonprofit?


Flag review
Review from Guidestar